{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:35:51Z","timestamp":1787963751866,"version":"build-2784847793"},"reference-count":59,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Changes have been made to the US federal 72-hour rule, which allows hospitals to administer or dispense but not prescribe up to 72 hours\u2019 worth of methadone for opioid withdrawal or opioid use disorder (OUD) at discharge (ie, take-home doses).<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To characterize acute care encounters involving take-home methadone and identify variables associated with completion of the transition from hospital to opioid treatment program (OTP) within 72 hours (hereafter 72-hour hospital to OTP linkage).<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study examined hospital and emergency department encounters for patients with OUD who received take-home methadone doses from 4 geographically diverse hospitals between November 2022 and April 2024.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n Receipt of take-home methadone at hospital discharge.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcome was documentation of 72-hour hospital to OTP linkage. Multinomial logistic regression was used to analyze the association between OTP linkage status (yes, no, or unknown) and discharge disposition, OTP enrollment at the time of the acute care encounter, co-use of opioids and stimulants, methadone dose, pregnancy, length of hospital stay, and psychiatric conditions.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Included in the analysis were 519 encounters for 456 individuals (median [IQR] age, 46 [36-56] years) who received take-home methadone at hospital discharge. Of these encounters, 280 (53.9%) involved patients who were male. Weekend discharge was the most common reason for dispensing take-home methadone doses (342 encounters [65.9%]). Overall, 231 encounters (44.5%) involved patients who completed a 72-hour hospital-to-OTP linkage, 67 encounters (12.9%) did not link to an OTP within 72 hours of discharge, and 221 (42.6%) had an unknown 72-hour OTP linkage status. Variables associated with completion of 72-hour hospital to OTP linkage included discharge to a postacute care facility (odds ratio [OR], 2.12; 95% CI, 1.12-4.21;\n P<\/jats:italic>\n \u2009=\u2009.02), OTP enrollment at the time of the acute care encounter (OR, 2.63; 95% CI, 1.48-4.79;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and increasing methadone dose in 10-mg increments (OR, 1.20; 95% CI, 1.09-1.33;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Co-use of opioids and stimulants was inversely associated with completion of the 72-hour hospital to OTP linkage (OR, 0.48; 95% CI, 0.26-0.87;\n P<\/jats:italic>\n \u2009=\u2009.01).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study, preexisting relationships between hospitals, postacute care facilities, and OTPs, along with provision of take-home methadone, likely facilitated OTP linkage. Expansion of these relationships and processes could facilitate OUD treatment engagement during tenuous care transitions.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.44996","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:30:35Z","timestamp":1763742635000},"page":"e2544996","source":"Crossref","is-referenced-by-count":2,"title":["Leveraging the 72-Hour Rule Change to Support Transition From Hospital to Opioid Treatment Program"],"prefix":"10.1001","volume":"8","author":[{"given":"Susan L.","family":"Calcaterra","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Hospital Medicine, University of Colorado, Aurora"},{"name":"Department of Medicine, Division of General Internal Medicine, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B.","family":"Weimer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hospital Medicine, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniya","family":"Scherbak","sequence":"additional","affiliation":[{"name":"UCHealth, University of Colorado Hospital, Aurora"},{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Abdel Galil","sequence":"additional","affiliation":[{"name":"Division of Addiction Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Johns Hopkins Bayview Medical Center, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Bowman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne A.","family":"Nesbit","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland"},{"name":"Office of Graduate Clinical Education, Johns Hopkins School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Barany","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Buresh","sequence":"additional","affiliation":[{"name":"Division of Addiction Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"},{"name":"Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"9","key":"zoi251216r2","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jhm.12893","article-title":"Management of opioid use disorder and associated conditions among hospitalized adults: a consensus statement from the Society of Hospital Medicine.","volume":"17","author":"Calcaterra","year":"2022","journal-title":"J Hosp Med"},{"issue":"7","key":"zoi251216r3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.23954","article-title":"Opioid overdose after medication for opioid use disorder initiation following hospitalization or ED visit.","volume":"7","author":"Weiner","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi251216r4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/CXA.0000000000000049","article-title":"The value of hospitalization in the opioid epidemic: a scoping review.","volume":"10","author":"Bahji","year":"2019","journal-title":"Can J Addict"},{"issue":"3","key":"zoi251216r5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi251216r6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi251216r7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence.","volume":"2010","author":"Faggiano","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"zoi251216r8","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"zoi251216r10","doi-asserted-by":"publisher","DOI":"10.4172\/2324-9005.1000138","article-title":"Managing opioid use disorder during and after acute hospitalization: a case-based review clarifying methadone regulation for acute care settings.","volume":"4","author":"Noska","year":"2015","journal-title":"J Addict Behav Ther Rehabil"},{"issue":"11","key":"zoi251216r13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1360-0443.1997.tb02866.x","article-title":"Patterns of symptom complaints in methadone maintenance patients.","volume":"92","author":"Dyer","year":"1997","journal-title":"Addiction"},{"key":"zoi251216r15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ajem.2024.12.059","article-title":"Emergency department utilization of the methadone \u201c72-hour rule\u201d to bridge or initiate and link to outpatient treatment.","volume":"89","author":"Huo","year":"2025","journal-title":"Am J Emerg Med"},{"issue":"11","key":"zoi251216r16","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1007\/s11606-021-07305-3","article-title":"Opioid use disorder treatment initiation and continuation: a qualitative study of patients who received addiction consultation and hospital-based providers.","volume":"37","author":"Calcaterra","year":"2022","journal-title":"J Gen Intern Med"},{"key":"zoi251216r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108708","article-title":"Experiences of stigma in hospitals with addiction consultation services: a qualitative analysis of patients\u2019 and hospital-based providers\u2019 perspectives.","volume":"138","author":"Hoover","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"zoi251216r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109763","article-title":"Transitions in care between hospital and community settings for individuals with a substance use disorder: a systematic review.","volume":"243","author":"James","year":"2023","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi251216r19","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1016\/S2468-2667(21)00007-4","article-title":"Periods of altered risk for non-fatal drug overdose: a self-controlled case series.","volume":"6","author":"Keen","year":"2021","journal-title":"Lancet Public Health"},{"issue":"4","key":"zoi251216r20","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s11606-020-06405-w","article-title":"Predicting mortality risk after a hospital or emergency department visit for nonfatal opioid overdose.","volume":"36","author":"Guo","year":"2021","journal-title":"J Gen Intern Med"},{"key":"zoi251216r21","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"zoi251216r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.039","article-title":"Touchpoints\u2014opportunities to predict and prevent opioid overdose: a cohort study.","volume":"204","author":"Larochelle","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi251216r24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/ajhp\/zxad288","article-title":"Operationalizing the new DEA exception: a novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings.","volume":"81","author":"Bowman","year":"2024","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"zoi251216r25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1097\/ADM.0000000000001246","article-title":"Dispensing methadone at hospital discharge: one hospital\u2019s approach to implementing the \u201c72-hour rule\u201d change.","volume":"18","author":"Skogrand","year":"2024","journal-title":"J Addict Med"},{"key":"zoi251216r26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109497","article-title":"Bridge clinic implementation of \u201c72-hour rule\u201d methadone for opioid withdrawal management: impact on opioid treatment program linkage and retention in care.","volume":"236","author":"Taylor","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi251216r29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1300\/J069v24n03_03","article-title":"Methadone dosage and retention: an examination of the 60 mg\/day threshold.","volume":"24","author":"Brady","year":"2005","journal-title":"J Addict Dis"},{"issue":"4","key":"zoi251216r30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/ADM.0000000000001473","article-title":"Relationship between methadone induction dosing and retention in treatment in opioid treatment programs.","volume":"19","author":"Sherrick","year":"2025","journal-title":"J Addict Med"},{"issue":"1","key":"zoi251216r31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/00952990802342899","article-title":"A meta-analysis of retention in methadone maintenance by dose and dosing strategy.","volume":"35","author":"Bao","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"zoi251216r32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1360-0443.1998.931516.x","article-title":"Pre- and in-treatment predictors of retention in methadone treatment using survival analysis.","volume":"93","author":"Magura","year":"1998","journal-title":"Addiction"},{"issue":"4","key":"zoi251216r33","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1037\/adb0000090","article-title":"Predictors of patient retention in methadone maintenance treatment.","volume":"29","author":"Proctor","year":"2015","journal-title":"Psychol Addict Behav"},{"issue":"1","key":"zoi251216r34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13722-021-00266-2","article-title":"The impact of methamphetamine\/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.","volume":"16","author":"Frost","year":"2021","journal-title":"Addict Sci Clin Pract"},{"issue":"9","key":"zoi251216r35","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1080\/10826084.2023.2212070","article-title":"Predictors of linkage to an opioid treatment program and methadone treatment retention following hospital discharge in a safety-net setting.","volume":"58","author":"Tierney","year":"2023","journal-title":"Subst Use Misuse"},{"issue":"6","key":"zoi251216r36","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1007\/s11469-022-00821-1","article-title":"Psychiatric comorbidities of substance use disorders: does dual diagnosis predict inpatient detoxification treatment outcomes?","volume":"21","author":"Davis","year":"2023","journal-title":"Int J Ment Health Addict"},{"issue":"5","key":"zoi251216r37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00737-023-01353-w","article-title":"Gender and addiction and other mental disorders comorbidity: sociodemographic, clinical, and treatment differences.","volume":"26","author":"Fern\u00e1ndez","year":"2023","journal-title":"Arch Womens Ment Health"},{"issue":"2","key":"zoi251216r38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0376-8716(01)00126-0","article-title":"Comorbidity between patterns of substance use dependence and psychiatric syndromes.","volume":"64","author":"Kandel","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"zoi251216r39","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.6069","article-title":"Medication for opioid use disorder and treatment retention among pregnant individuals.","volume":"8","author":"Ganetsky","year":"2025","journal-title":"JAMA Netw Open"},{"key":"zoi251216r40","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jsat.2017.06.005","article-title":"Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder.","volume":"80","author":"Wilder","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"zoi251216r41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/a-2508-7086","article-title":"Academic detailing to enhance adoption of clinical decision support for patients at risk of opioid overdose.","volume":"16","author":"Hussain","year":"2025","journal-title":"Appl Clin Inform"},{"key":"zoi251216r42","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-025-09772-4","article-title":"Clinical decision support to increase naloxone co-prescribing from the inpatient setting.","author":"Lebin","year":"2025","journal-title":"J Gen Intern Med"},{"issue":"1","key":"zoi251216r43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/10550887.2010.531672","article-title":"Effect of methadone maintenance treatment on heroin craving: a literature review.","volume":"30","author":"Fareed","year":"2011","journal-title":"J Addict Dis"},{"issue":"6","key":"zoi251216r44","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone matters: what the United States can learn from the global effort to treat opioid addiction.","volume":"34","author":"Calcaterra","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"6","key":"zoi251216r45","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/jhm.13329","article-title":"Unintended consequences of methadone regulation for opioid use disorder treatment among hospitalized patients.","volume":"19","author":"Calcaterra","year":"2024","journal-title":"J Hosp Med"},{"issue":"9","key":"zoi251216r46","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","article-title":"Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis.","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"zoi251216r47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11606-023-08411-0","article-title":"In-hospital methadone enrollment: a novel program to facilitate linkage from the hospital to the opioid treatment program for vulnerable patients with opioid use disorder.","volume":"39","author":"Calcaterra","year":"2024","journal-title":"J Gen Intern Med"},{"key":"zoi251216r48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","article-title":"Addiction consultation services\u2014linking hospitalized patients to outpatient addiction treatment.","volume":"79","author":"Trowbridge","year":"2017","journal-title":"J Subst Abuse Treat"},{"key":"zoi251216r49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108895","article-title":"OUD MEETS: A novel program to increase initiation of medications for opioid use disorder and improve outcomes for hospitalized patients being discharged to skilled nursing facilities.","volume":"143","author":"Tassey","year":"2022","journal-title":"J Subst Abuse Treat"},{"key":"zoi251216r50","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001562","article-title":"Implementing a collaborative approach to caring for patients with substance use disorders requiring outpatient parenteral antimicrobial therapy after discharge.","author":"Keller","year":"2025","journal-title":"J Addict Med"},{"key":"zoi251216r51","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001591","article-title":"Estimated hospital cost reduction following implementation of hospital-dispensed discharge methadone.","author":"Calcaterra","year":"2025","journal-title":"J Addict Med"},{"issue":"10","key":"zoi251216r53","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jamapsychiatry.2021.1969","article-title":"Contingency management for patients receiving medication for opioid use disorder: a systematic review and meta-analysis.","volume":"78","author":"Bol\u00edvar","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"zoi251216r54","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1097\/ADM.0000000000001183","article-title":"Adapting contingency management for hospitalized patients with stimulant use disorder.","volume":"17","author":"Peng","year":"2023","journal-title":"J Addict Med"},{"issue":"2","key":"zoi251216r55","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/ADM.0000000000001254","article-title":"The IMPACT (infection management plus addiction care together) pilot: a case series of combined contingency management for substance use disorders and antibiotic adherence in the hospital setting.","volume":"18","author":"Appa","year":"2024","journal-title":"J Addict Med"},{"key":"zoi251216r56","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.tranpol.2024.08.001","article-title":"Affordable transportation access to treatment for opioid use disorder.","volume":"156","author":"Ngo","year":"2024","journal-title":"Transp Policy"},{"issue":"2","key":"zoi251216r57","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0209","article-title":"Accessibility of opioid treatment programs based on conventional vs perceived travel time measures.","volume":"7","author":"Kim","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi251216r58","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1080\/10826084.2022.2112229","article-title":"Opioid-involved overdose vulnerability in Wyoming: measuring risk in a rural environment.","volume":"57","author":"Pustz","year":"2022","journal-title":"Subst Use Misuse"},{"issue":"13","key":"zoi251216r59","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 US states.","volume":"322","author":"Joudrey","year":"2019","journal-title":"JAMA"},{"key":"zoi251216r12"},{"key":"zoi251216r27"},{"key":"zoi251216r1","unstructured":"Ahmad? FBCJ, Rossen? LM, Sutton? P. Provisional drug overdose death counts. National Center for Health Statistics. Accessed November 27, 2023. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"zoi251216r9","unstructured":"Administering or dispensing of narcotic drugs. 21 CFR \u00a71306.07. (2025). Accessed August 30, 2025. https:\/\/www.ecfr.gov\/current\/title-21\/chapter-II\/part-1306\/subject-group-ECFR1eb5bb3a23fddd0\/section-1306.07?"},{"key":"zoi251216r11","unstructured":"Federal guidelines for opioid treatment programs. Substance Abuse and Mental Health Services Administration. 2024. Accessed October 16, 2025. https:\/\/www.med.unc.edu\/fammed\/nctac\/wp-content\/uploads\/sites\/1256\/2025\/01\/federal-guidelines-opioid-treatment-pep24-02-011-1.pdf"},{"key":"zoi251216r14","unstructured":"Dispensing of narcotic drugs to relieve acute withdrawal symptoms of opioid use disorder. 21 CFR \u00a71306.07. Accessed October 31, 2025. https:\/\/www.federalregister.gov\/documents\/2023\/08\/08\/2023-16892\/dispensing-of-narcotic-drugs-to-relieve-acute-withdrawal-symptoms-of-opioid-use-disorder"},{"key":"zoi251216r23","unstructured":"Request for exception to limitations on dispensing for OUD. US Department of Justice, Drug Enforcement Administration. January 12, 2023. Accessed May 13, 2025. https:\/\/www.deadiversion.usdoj.gov\/drugreg\/Instructions-to-request-exception-to-21-CFR-1306.07(b)-3-day-rule-(EO-DEA248R1).pdf"},{"key":"zoi251216r28","unstructured":"Practitioner\u2019s manual: an informational outline of the controlled substances act. United States Department of Justice, Drug Enforcement Administration, Diversion Control Division. 2023. Accessed June 10, 2025. https:\/\/www.deadiversion.usdoj.gov\/GDP\/(DEA-DC-071)(EO-DEA226)_Practitioner's_Manual_(final).pdf"},{"key":"zoi251216r52","unstructured":"Strategies for supporting residents with opioid use disorder in long term care. Connecticut Department of Mental Health and Addiction Services. Accessed June 21, 2025. https:\/\/portal.ct.gov\/-\/media\/dmhas\/publications\/toolkit---strategies-for-supporting-residents-with-oud-in-long-term-care.pdf?rev=d1501aa0d4eb47f28b2461940da46f77"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2841744\/calcaterra_2025_oi_251216_1763141588.56199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:30:37Z","timestamp":1763742637000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2841744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.44996","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}